Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2002 1
2005 1
2006 1
2007 1
2008 3
2009 2
2010 1
2011 1
2012 1
2013 1
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Mood effect of raloxifene in postmenopausal women.
Jarkova NB, Martenyi F, Masanauskaite D, Walls EL, Smetnik VP, Pavo I. Jarkova NB, et al. Among authors: masanauskaite d. Maturitas. 2002 May 20;42(1):71-5. doi: 10.1016/s0378-5122(01)00303-6. Maturitas. 2002. PMID: 12020982 Clinical Trial.
Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study.
Delmas PD, Adami S, Strugala C, Stakkestad JA, Reginster JY, Felsenberg D, Christiansen C, Civitelli R, Drezner MK, Recker RR, Bolognese M, Hughes C, Masanauskaite D, Ward P, Sambrook P, Reid DM. Delmas PD, et al. Among authors: masanauskaite d. Arthritis Rheum. 2006 Jun;54(6):1838-46. doi: 10.1002/art.21918. Arthritis Rheum. 2006. PMID: 16729277 Free article. Clinical Trial.
Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II).
Hadji P, Minne H, Pfeifer M, Bourgeois P, Fardellone P, Licata A, Devas V, Masanauskaite D, Barrett-Connor E. Hadji P, et al. Among authors: masanauskaite d. Joint Bone Spine. 2008 May;75(3):303-10. doi: 10.1016/j.jbspin.2007.07.011. Epub 2007 Oct 22. Joint Bone Spine. 2008. PMID: 18069036 Clinical Trial.
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
Eisman JA, Civitelli R, Adami S, Czerwinski E, Recknor C, Prince R, Reginster JY, Zaidi M, Felsenberg D, Hughes C, Mairon N, Masanauskaite D, Reid DM, Delmas PD, Recker RR. Eisman JA, et al. Among authors: masanauskaite d. J Rheumatol. 2008 Mar;35(3):488-97. Epub 2008 Feb 1. J Rheumatol. 2008. PMID: 18260172 Clinical Trial.
Oral ibandronate preserves trabecular microarchitecture: micro-computed tomography findings from the oral iBandronate Osteoporosis vertebral fracture trial in North America and Europe study.
Recker RR, Ste-Marie LG, Langdahl B, Masanauskaite D, Ethgen D, Delmas PD. Recker RR, et al. Among authors: masanauskaite d. J Clin Densitom. 2009 Jan-Mar;12(1):71-6. doi: 10.1016/j.jocd.2008.10.006. Epub 2008 Dec 11. J Clin Densitom. 2009. PMID: 19084450 Clinical Trial.